Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer

BackgroundAlthough tertiary lymphoid structures (TLS) play crucial roles in the anti-tumor immune response and are associated with favorable prognoses in many solid tumors, the precise mechanisms by which TLSs enhance anti-tumor immunity remain poorly understood. The current study aimed to explore t...

Full description

Saved in:
Bibliographic Details
Main Authors: Qin Fang, Shuru Chen, Xiaoyue Chen, Wei Zou, Di Chen, Yukang Huang, Chucheng Wu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1480461/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832589836224036864
author Qin Fang
Shuru Chen
Xiaoyue Chen
Wei Zou
Di Chen
Yukang Huang
Chucheng Wu
author_facet Qin Fang
Shuru Chen
Xiaoyue Chen
Wei Zou
Di Chen
Yukang Huang
Chucheng Wu
author_sort Qin Fang
collection DOAJ
description BackgroundAlthough tertiary lymphoid structures (TLS) play crucial roles in the anti-tumor immune response and are associated with favorable prognoses in many solid tumors, the precise mechanisms by which TLSs enhance anti-tumor immunity remain poorly understood. The current study aimed to explore the relationship between the maturity of tertiary lymphoid structures and their key immune cells in combating breast cancer.Patients and methodsIn this study, we utilized immunofluorescence and H&E staining to detect tumor-resident memory T cells (Trm) and assess the maturity of TLS, analyzing their distribution and proportion in an annotated cohort of 95 breast cancer patients.ResultsThe presence of tumor-associated TLSs was correlated with an improved prognosis in patients with breast cancer. The proportion of CD8+CD103+ resident memory T cells and natural killer (NK) cells within the TLSs was significantly higher than that in areas outside of these structures. Additionally, the proportions of CD103+ CD8+ Trm cells and NK cells were significantly increased with the gradual maturation of TLS. Furthermore, the secretion function of effector molecules by CD8+ CD103+ Trm cells and NK cells within TLSs was significantly enhanced, indicating a strong correlation between the effector function of CD103+ CD8+ Trm and NK cells and the maturity of TLSs.ConclusionOur study identifies potential additional prognostic information for the clinical prognosis of breast cancer patients, underscoring the prognostic significance of immune cells within TLS, with a particular focus on CD103+ CD8+ Trm cells and NK cells.
format Article
id doaj-art-4e0ccbd98ce6432bb8e4ed4c9f2ac3bd
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-4e0ccbd98ce6432bb8e4ed4c9f2ac3bd2025-01-24T07:14:24ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011510.3389/fonc.2025.14804611480461Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancerQin FangShuru ChenXiaoyue ChenWei ZouDi ChenYukang HuangChucheng WuBackgroundAlthough tertiary lymphoid structures (TLS) play crucial roles in the anti-tumor immune response and are associated with favorable prognoses in many solid tumors, the precise mechanisms by which TLSs enhance anti-tumor immunity remain poorly understood. The current study aimed to explore the relationship between the maturity of tertiary lymphoid structures and their key immune cells in combating breast cancer.Patients and methodsIn this study, we utilized immunofluorescence and H&E staining to detect tumor-resident memory T cells (Trm) and assess the maturity of TLS, analyzing their distribution and proportion in an annotated cohort of 95 breast cancer patients.ResultsThe presence of tumor-associated TLSs was correlated with an improved prognosis in patients with breast cancer. The proportion of CD8+CD103+ resident memory T cells and natural killer (NK) cells within the TLSs was significantly higher than that in areas outside of these structures. Additionally, the proportions of CD103+ CD8+ Trm cells and NK cells were significantly increased with the gradual maturation of TLS. Furthermore, the secretion function of effector molecules by CD8+ CD103+ Trm cells and NK cells within TLSs was significantly enhanced, indicating a strong correlation between the effector function of CD103+ CD8+ Trm and NK cells and the maturity of TLSs.ConclusionOur study identifies potential additional prognostic information for the clinical prognosis of breast cancer patients, underscoring the prognostic significance of immune cells within TLS, with a particular focus on CD103+ CD8+ Trm cells and NK cells.https://www.frontiersin.org/articles/10.3389/fonc.2025.1480461/fullbreast cancertertiary lymphoid structuresCD103+ CD8+ Trm cellsprognosis factorstumor immunology
spellingShingle Qin Fang
Shuru Chen
Xiaoyue Chen
Wei Zou
Di Chen
Yukang Huang
Chucheng Wu
Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
Frontiers in Oncology
breast cancer
tertiary lymphoid structures
CD103+ CD8+ Trm cells
prognosis factors
tumor immunology
title Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
title_full Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
title_fullStr Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
title_full_unstemmed Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
title_short Mature tertiary lymphoid structure associated CD103+ CD8+ Trm cells determined improved anti-tumor immune in breast cancer
title_sort mature tertiary lymphoid structure associated cd103 cd8 trm cells determined improved anti tumor immune in breast cancer
topic breast cancer
tertiary lymphoid structures
CD103+ CD8+ Trm cells
prognosis factors
tumor immunology
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1480461/full
work_keys_str_mv AT qinfang maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT shuruchen maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT xiaoyuechen maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT weizou maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT dichen maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT yukanghuang maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer
AT chuchengwu maturetertiarylymphoidstructureassociatedcd103cd8trmcellsdeterminedimprovedantitumorimmuneinbreastcancer